Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
88
datasets available to search
ShareScore release 0.9.0
Dataset results
88 results for “Tricuspid regurgitation”
Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection Fraction
ClinicalTrials.gov study NCT05209919. IPD Sharing: NO. Countries: 1. Publications: 1.
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia
ClinicalTrials.gov study NCT01783093. IPD Sharing: Not stated. Countries: 1. Publications: 5.
The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System
ClinicalTrials.gov study NCT02787408. IPD Sharing: NO. Countries: 5. Publications: 0.
Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System
ClinicalTrials.gov study NCT05173233. IPD Sharing: YES. Countries: 0. Publications: 3.
Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)
ClinicalTrials.gov study NCT02339974. IPD Sharing: NO. Countries: 1. Publications: 0.
Tricuspid Regurgitation Study
ClinicalTrials.gov study NCT01093001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ATRIAL SECONDARY TRICUSPID REGURGITATION
<p><span>Echocardiographic studies prospectively acquired from patients with secondary tricuspid regurgitation (STR) between October 2010 and March 2022. Inclusion criteria were age >18 years and presence of STR. </span><span>Atrial STR was defined by the presence of STR in patients with a clinical history of atrial fibrillation (AF), normal left ventricular (LV) systolic function, normal right ventricular (RV) size and/or function, and pulmonary artery systolic pressure (PASP) lower than 50 mmHg (2). The rest of the patients were included in the ventricular STR phenotype. </span><span>Exclusion criteria were primary TR, cardiac implantable electronic device (CIED)-related TR (leaflet impingement, adherence, etc.), previous TV surgery or transcatheter treatment, pregnancy, poor apical acoustic window with inadequate echocardiographic images, and lack of follow-up data. </span></p> <p><span>The primary study endpoint was the occurrence of death for any cause or hospitalization for HF. Information concerning survival and hospitalization was obtained at regular intervals via (i) telephone interview with the patient, or if deceased, with family members; (ii) contact with the patient’s physician(s); and (iii) review of electronic medical records of regular outpatient visits and hospital admission records. Mortality status was verified independently through the Social Security Death Index and death certificates. Cause of death was determined based on a review of death certificates, post-mortem exam reports when available, medical records for patients who died while hospitalized, and contact of patient’s physician(s), and it was classified as cardiac or non-cardiac death. HF hospitalization was defined as admission for more than 24 hours with a primary diagnosis of HF, characterized by symptoms, signs, laboratory and/or invasive HF findings, and HF-specific treatment implementation. Assignment of clinical events was performed by physicians unaware of the patient's echocardiographic data. For patients without events, the date of last contact was used for survival analysis.</span></p>
Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery
ClinicalTrials.gov study NCT06554119. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation
ClinicalTrials.gov study NCT03159923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognostic Value of Early Postoperative Right Ventricular Systolic Function in Patients With Isolated Severe Tricuspid Regurgitation
ClinicalTrials.gov study NCT01203137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
ClinicalTrials.gov study NCT05848284. IPD Sharing: NO. Countries: 2. Publications: 0.
The Long-term Course of Moderate Tricuspid Regurgitation
ClinicalTrials.gov study NCT06169345. IPD Sharing: NO. Countries: 1. Publications: 0.
Acute Safety and Efficacy of the Pivot Bridge System for Functional Tricuspid Regurgitation
ClinicalTrials.gov study NCT07385625. IPD Sharing: NO. Countries: 1. Publications: 0.
Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation
ClinicalTrials.gov study NCT07042360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation
ClinicalTrials.gov study NCT05628779. IPD Sharing: YES. Countries: 1. Publications: 0.
Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography
ClinicalTrials.gov study NCT05130775. IPD Sharing: YES. Countries: 1. Publications: 0.
Cardiac Synchronization and Tricuspid Regurgitation With Leadless Pacemaker
ClinicalTrials.gov study NCT05817695. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SGLT2 Inhibitor for Severe Tricuspid Regurgitation
ClinicalTrials.gov study NCT05686616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation
ClinicalTrials.gov study NCT04173091. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation
ClinicalTrials.gov study NCT01502462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.